Jpmorgan Chase & CO Tg Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 450,512 shares of TGTX stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

450,512

Previous 364,675 23.54%

Holding current value

$10.7 Million

Previous $5.55 Million 44.5%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$13.32 - $19.19 $1.14 Million - $1.65 Million	85,837 Added 23.54%	450,512 $8.01 Million
Q1 2024 May 10, 2024	BUY	$13.02 - $21.3 $1.27 Million - $2.09 Million	97,907 Added 36.7%	364,675 $5.55 Million
Q4 2023 Feb 12, 2024	BUY	$6.68 - $18.81 $415,616 - $1.17 Million	62,218 Added 30.42%	266,768 $4.56 Million
Q3 2023 Nov 14, 2023	SELL	$8.36 - $26.5 $588,711 - $1.87 Million	-70,420 Reduced 25.61%	204,550 $1.71 Million
Q2 2023 Aug 11, 2023	SELL	$15.48 - $35.0 $2.01 Million - $4.54 Million	-129,778 Reduced 32.06%	274,970 $6.83 Million
Q1 2023 May 18, 2023	BUY	$10.23 - $19.34 $1.74 Million - $3.28 Million	169,664 Added 72.17%	404,748 $6.09 Million
Q1 2023 May 11, 2023	SELL	$10.23 - $19.34 $539,448 - $1.02 Million	-52,732 Reduced 18.32%	235,084 $3.54 Million
Q4 2022 Feb 13, 2023	SELL	$5.01 - $11.83 $4,719 - $11,143	-942 Reduced 0.33%	287,816 $3.41 Million
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $10,195 - $18,740	-2,231 Reduced 0.77%	288,758 $1.71 Million
Q2 2022 Aug 11, 2022	BUY	$3.74 - $10.66 $84,280 - $240,223	22,535 Added 8.39%	290,989 $1.24 Million
Q1 2022 May 11, 2022	BUY	$7.81 - $20.45 $65,158 - $170,614	8,343 Added 3.21%	268,454 $2.55 Million
Q4 2021 Feb 10, 2022	BUY	$15.2 - $35.51 $1.51 Million - $3.54 Million	99,635 Added 62.09%	260,111 $4.94 Million
Q3 2021 Nov 12, 2021	BUY	$21.78 - $40.45 $3.5 Million - $6.49 Million	160,476 New	160,476 $5.34 Million

Others Institutions Holding TGTX

# of Institutions

287

Shares Held

91.8M

Call Options Held

1.9M

Put Options Held

1.45M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.46B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Tg Therapeutics, Inc. Transaction History